<DOC>
	<DOCNO>NCT00040001</DOCNO>
	<brief_summary>This study design evaluate safety DTI-0009 patient atrial fibrillation find dose DTI-0009 lower heart rate patient atrial fibrillation rapid ventricular response .</brief_summary>
	<brief_title>Safety Efficacy Study A1-Adenosine Receptor Agonist Slow Heart Rate Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Inclusion Criteria Primary diagnosis atrial fibrillation rapid ventricular response duration document ECG Exclusion Criteria Presence significant cardiac disease history significant neurological , hepatic , cardiovascular , renal , gastrointestinal , thyroid , respiratory , rheumatologic , hematologic disease impairment investigator â€™ judgment serious enough preclude patient safely participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2003</verification_date>
</DOC>